Alexion Pharmaceuticals, Inc. (ALXN): Price and Financial Metrics
Alexion Pharmaceuticals, Inc. (ALXN)
Today's Latest Price: $113.27 USD
0.76 (0.68%)
Updated Jan 17 12:00am
Add ALXN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ALXN Stock Summary
- Alexion Pharmaceuticals Inc's market capitalization of $24,901,841,458 is ahead of 91.82% of US-listed equities.
- With a year-over-year growth in debt of -15.77%, Alexion Pharmaceuticals Inc's debt growth rate surpasses merely 15.92% of about US stocks.
- Over the past twelve months, ALXN has reported earnings growth of 250.11%, putting it ahead of 95.11% of US stocks in our set.
- Stocks that are quantitatively similar to ALXN, based on their financial statements, market capitalization, and price volatility, are FCAU, IQ, CMI, GLW, and ZBRA.
- Visit ALXN's SEC page to see the company's official filings. To visit the company's web site, go to www.alexion.com.
ALXN Daily Price Range
ALXN 52-Week Price Range
ALXN Stock Price Chart More Charts
ALXN Price/Volume Stats
| Current price | $113.27 | 52-week high | $141.86 |
| Prev. close | $112.51 | 52-week low | $94.59 |
| Day low | $112.47 | Volume | 1,938,400 |
| Day high | $114.35 | Avg. volume | 1,833,267 |
| 50-day MA | $110.32 | Dividend yield | N/A |
| 200-day MA | $115.43 | Market Cap | 25.07B |
Alexion Pharmaceuticals, Inc. (ALXN) Company Bio
Alexion Pharmaceuticals a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company was founded in 1992 and is based in Cheshire, Connecticut.
Top Stories View All
3 Vital Investing Strategies
Best & Worst Performing Stock Industries for January 17, 2020
Best & Worst Performing Small Cap Stocks for January 17, 2020
Best & Worst Performing Mid Cap Stocks for January 17, 2020
Best & Worst Performing Large Cap Stocks for January 17, 2020
View All Top Stories
Loading social stream, please wait...